BusinessMelinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDABy Nasdaq OMXJan 5, 2017, 1:01 PM UTC
BusinessMelinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDABy Nasdaq OMXJan 5, 2017, 1:01 PM UTC